Invesco
KYNB

Invesco’s Kyntra Bio KYNB Stock Holding History

Invesco’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,837
Closed -$48.3K – 3779
2024
Q3 		$48.3K Buy
4,837
+3,460
+251% +$52.2K ﹤0.01% 3689
2024
Q2 		$30.7K Sell
1,377
-215
-14% -$6.64K ﹤0.01% 3858
2024
Q1 		$93.5K Sell
1,592
-624
-28% -$26.9K ﹤0.01% 3749
2023
Q4 		$49.1K Sell
2,216
-1,666
-43% -$25.1K ﹤0.01% 3751
2023
Q3 		$83.7K Buy
3,882
+1,765
+83% +$69.3K ﹤0.01% 3744
2023
Q2 		$143K Sell
2,117
-16,843
-89% -$6.97M ﹤0.01% 3673
2023
Q1 		$8.84M Buy
18,960
+15,749
+490% +$8.33M ﹤0.01% 1890
2022
Q4 		$1.29M Sell
3,211
-19,654
-86% -$7.53M ﹤0.01% 2822
2022
Q3 		$7.44M Buy
22,865
+19,658
+613% +$6.33M ﹤0.01% 1982
2022
Q2 		$847K Sell
3,207
-16,894
-84% -$4.32M ﹤0.01% 3058
2022
Q1 		$6.04M Buy
20,101
+17,498
+672% +$6.1M ﹤0.01% 2280
2021
Q4 		$918K Buy
2,603
+429
+20% +$134K ﹤0.01% 3110
2021
Q3 		$555K Sell
2,174
-14,226
-87% -$5.04M ﹤0.01% 3387
2021
Q2 		$10.9M Buy
16,400
+8,812
+116% +$5.08M ﹤0.01% 1997
2021
Q1 		$6.58M Buy
7,588
+293
+4% +$312K ﹤0.01% 2224
2020
Q4 		$6.76M Buy
7,295
+770
+12% +$809K ﹤0.01% 2023
2020
Q3 		$6.71M Buy
6,525
+5,820
+826% +$6.26M ﹤0.01% 1857
2020
Q2 		$715K Sell
705
-5,717
-89% -$5.31M ﹤0.01% 2968
2020
Q1 		$5.58M Buy
6,422
+5,903
+1,137% +$5.87M ﹤0.01% 1813
2019
Q4 		$556K Sell
519
-5,311
-91% -$5.42M ﹤0.01% 3204
2019
Q3 		$5.39M Sell
5,830
-12,232
-68% -$13.4M ﹤0.01% 2089
2019
Q2 		$20.4M Buy
18,062
+12,261
+211% +$13.4M 0.01% 1422
2019
Q1 		$7.88M Sell
5,801
-1,447
-20% -$1.96M ﹤0.01% 1715
2018
Q4 		$8.38M Buy
7,248
+3,099
+75% +$3.48M ﹤0.01% 1622
2018
Q3 		$6.3M Buy
4,149
+1,793
+76% +$2.76M ﹤0.01% 2018
2018
Q2 		$3.69M Buy
2,356
+2,182
+1,254% +$2.84M ﹤0.01% 2349
2018
Q1 		$201K Sell
174
-7,013
-98% -$9.24M ﹤0.01% 3596
2017
Q4 		$8.52M Sell
7,187
-973
-12% -$1.22M ﹤0.01% 1667
2017
Q3 		$11M Sell
8,160
-5,367
-40% -$5.66M ﹤0.01% 1513
2017
Q2 		$10.9M Buy
13,527
+8,087
+149% +$5.63M ﹤0.01% 1501
2017
Q1 		$3.35M Sell
5,440
-250
-4% -$152K ﹤0.01% 2255
2016
Q4 		$3.04M Sell
5,690
-3,957
-41% -$1.98M ﹤0.01% 2298
2016
Q3 		$4.99M Sell
9,647
-706
-7% -$333K ﹤0.01% 1978
2016
Q2 		$4.25M Buy
10,353
+2,028
+24% +$929K ﹤0.01% 2035
2016
Q1 		$4.43M Buy
+8,325
New +$4.15M ﹤0.01% 1958
2015
Q4 		– Sell
-1,275
Closed -$699K – 3751
2015
Q3 		$699K Sell
1,275
-519
-29% -$314K ﹤0.01% 3096
2015
Q2 		$1.05M Buy
+1,794
New +$1.04M ﹤0.01% 3041
2015
Q1 		– Sell
-1,721
Closed -$1.18M – 4028
2014
Q4 		$1.18M Buy
+1,721
New +$1.11M ﹤0.01% 2856

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Invesco's KYNB Position: Q4 2024 in Review

Invesco sold out of Kyntra Bio (KYNB) in Q4 2024, closing a stake of 4,837 shares — an estimated $48.3K sold.

Invesco first reported a position in KYNB in Q4 2014 and held it in 38 quarters. The position peaked at $20.4M in Q2 2019. 68 funds tracked by Wall St. Rank hold KYNB as of Q4 2024.

  • Invesco reported no remaining Kyntra Bio position as of Q4 2024 after selling out during the quarter.
  • Invesco sold 4,837 Kyntra Bio shares in Q4 2024, an estimated $48.3K.
  • Invesco first reported a position in Kyntra Bio in Q4 2014 and held it in 38 quarters.
  • Invesco's Kyntra Bio position peaked at $20.4M in Q2 2019.
  • 68 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2024.

Based on Invesco's 13F filing for Q4 2024, filed 13 Feb 2025.